Senti banks $105M series B as Bayer continues to show enthusiasm for gene and cell therapy biotechs
Biotech has aligned its internal focus on CAR NKs, but may partner elsewhere
The biotech has aligned its internal focus on CAR NKs, but may partner its gene circuits in other areas.
Jan 6, 2021 | 11:14 PM GMT
The latest signal of Bayer’s growing interest in gene and cell therapies